The frequency of high PD-L1 expression is low in lung adenocarcinoma patients from Northeast Brazil

• Κύριοι συγγραφείς: Antonio V. Alves da Silva (Συγγραφέας), Francisco Martins Neto (Συγγραφέας), Ana Claudia da Silva M. de Oliveira (Συγγραφέας), Benedito A. Carneiro (Συγγραφέας), Marclesson Alves (Συγγραφέας), Cleto Dantas Nogueira (Συγγραφέας), Fabio Tavora (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BMC, 2019-02-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Background As Immune checkpoint inhibitors (ICPIs) are changing the standard-care in lung cancer with good clinical activities and durable responses, its indication must be based on the appropriate patient selection once only a fraction of patients has a response to these costly drugs. In l...